Can naltrexone be added to a regimen of Pristiq (desvenlafaxine) 50mg every night (q HS), Lamictal (lamotrigine) 200mg every morning (q AM), Seroquel XR (quetiapine) 50mg every night (q HS), and Trazodone 50mg every night (q HS) for weight loss and heavy appetite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Naltrexone Be Added for Weight Loss and Appetite Control?

Yes, naltrexone-bupropion combination can be added to this regimen, but naltrexone monotherapy alone is not effective for weight loss and should not be used. 1, 2

Critical Drug Interaction Assessment

Serotonin Syndrome Risk - Moderate Concern

  • The combination of Pristiq (desvenlafaxine, an SNRI) with bupropion creates additive serotonergic effects that require monitoring but is not an absolute contraindication. 1
  • Trazodone (50mg) adds additional serotonergic activity, further increasing theoretical risk of serotonin syndrome when combined with bupropion. 1
  • Monitor closely for serotonin syndrome symptoms: agitation, confusion, tremor, tachycardia, hyperthermia, and hyperreflexia during the first 2-4 weeks of naltrexone-bupropion initiation. 1

Seizure Risk - Major Concern

  • Bupropion lowers seizure threshold, and the combination with Lamictal (an antiepileptic) creates a complex interaction. 1
  • Lamictal 200mg suggests this patient has either epilepsy or bipolar disorder - both are relative contraindications for naltrexone-bupropion. 1
  • If Lamictal is for seizure disorder: naltrexone-bupropion is absolutely contraindicated. 1
  • If Lamictal is for bipolar disorder: naltrexone-bupropion can be used with extreme caution, as bupropion carries risk of precipitating mania. 3

Quetiapine (Seroquel XR) Interaction

  • Seroquel XR 50mg is likely being used for sleep or mood augmentation given the low dose. 1
  • Bupropion may reduce the sedative effects of quetiapine and can lower the seizure threshold when combined with antipsychotics. 1
  • No direct pharmacokinetic interaction, but monitor for reduced sleep quality. 1

Recommended Approach

If Lamictal is for Seizure Disorder:

Do not add naltrexone-bupropion. Consider alternative weight loss medications instead: 1

  • First-line alternative: Semaglutide 2.4mg subcutaneous weekly - most effective option with 10.3-12.4% total body weight loss, no seizure risk, and compatible with this medication regimen. 1
  • Second-line alternative: Liraglutide 3.0mg subcutaneous daily - 5.8-5.9% weight loss, no seizure or serotonergic interactions. 1

If Lamictal is for Bipolar Disorder or Off-Label Use:

Naltrexone-bupropion can be cautiously added with intensive monitoring: 1, 2

FDA-Approved Titration Schedule:

  • Week 1: One 8mg naltrexone/90mg bupropion tablet each morning. 1, 2
  • Week 2: One tablet twice daily (morning and evening). 1, 2
  • Week 3: Two tablets in morning, one tablet in evening. 2
  • Week 4 onward: Two tablets twice daily (total daily dose: 32mg naltrexone/360mg bupropion). 1, 2

Mandatory Monitoring Protocol:

  • Blood pressure and heart rate at baseline, weekly during titration, then monthly - bupropion has sympathomimetic effects that can elevate both. 1, 3
  • Mental status assessment at each visit - monitor for mood destabilization, anxiety, agitation, or emergence of manic symptoms. 3, 4
  • Discontinue if <5% total body weight loss after 12 weeks on maintenance dose - patient is a non-responder. 1

Expected Efficacy

  • Mean weight loss: 6.1% at 56 weeks (vs 1.3% with placebo). 1, 2
  • 48% of patients achieve ≥5% body weight loss. 1, 2
  • Particularly effective for patients with food cravings and hedonic eating behaviors - the mechanism targets reward pathways through dopamine/norepinephrine modulation. 2, 5, 6

Common Side Effects to Anticipate

  • Nausea (most common, occurs in ~30% of patients) - typically improves after 4-6 weeks, can be mitigated by slow titration. 1, 3
  • Constipation, headache, dizziness, insomnia, dry mouth. 1, 3
  • Insomnia may be particularly problematic given patient is already taking trazodone 50mg for sleep - may need to increase trazodone dose. 3

Absolute Contraindications to Verify

  • Uncontrolled hypertension - check baseline blood pressure before initiating. 1, 3
  • Current or anticipated opioid use - naltrexone blocks opioid receptors and will precipitate withdrawal or block pain medication efficacy. 1, 2
  • Eating disorders (anorexia/bulimia) - bupropion increases seizure risk in these conditions. 1
  • Abrupt discontinuation of alcohol or benzodiazepines - increases seizure risk with bupropion. 1
  • Pregnancy or breastfeeding - teratogenic concerns with bupropion. 1, 3

Clinical Pitfalls to Avoid

  • Do not use naltrexone monotherapy - it has no appreciable effect on weight loss and only works synergistically with bupropion. 7, 8
  • Do not combine with MAOIs - must have 14-day washout period. 1
  • Do not ignore the seizure risk - this is the most serious potential complication in this polypharmacy regimen. 1
  • Gradual titration is mandatory - rapid dose escalation significantly increases nausea and dropout rates. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Naltrexone and Bupropion for Food Cravings: Separate vs. Combined Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Naltrexone Side Effects and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alcohol and Contrave Interactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Combination therapy with naltrexone and bupropion for obesity.

Expert opinion on pharmacotherapy, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.